{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T16:54:43Z","timestamp":1776012883825,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG042066"],"award-info":[{"award-number":["R21AG042066"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Frontotemporal dementia (FTD) is the second leading cause of early onset dementia following Alzheimer\u2019s disease. It involves atrophy of the frontal and temporal regions of the brain affecting language, memory, and behavior. Transactive response DNA-binding protein 43 (TDP-43) pathology is found in most FTD and ALS cases. It plays a role in transcription, translation and serves as a shuttle between the nucleus and cytoplasm. Prior to its aggregation, TDP-43 exists as polyubiquitinated, hyperphosphorylated C-terminal fragments that correlate well with FTD disease progression. Because of the importance of TDP-43 in these diseases, reagents that can selectively recognize specific toxic TDP variants associated with onset and progression of FTD can be effective diagnostic and therapeutic tools.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>We utilized a novel atomic force microscopy (AFM) based biopanning protocol to isolate single chain variable fragments (scFvs) from a phage display library that selectively bind TDP variants present in human FTD but not cognitively normal age matched brain tissue. We then used the scFvs (FTD-TDP1 through 5) to probe post-mortem brain tissue and sera samples for the presence of FTD related TDP variants. The scFvs readily selected the FTD tissue and sera samples over age matched controls. The scFvs were used in immunohistochemical analysis of FTD and control brain slices where the reagents showed strong staining with TDP in FTD brain tissue slice. FTD-TDP1, FTD-TDP2, FTD-TDP4 and FTD-TDP5 all protected neuronal cells against FTD TDP induced toxicity suggesting potential therapeutic value.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>These results show existence of different disease specific TDP variants in FTD individuals. We have identified a panel of scFvs capable of recognizing these disease specific TDP variants in postmortem FTD tissue and sera samples over age matched controls and can thus serve as a biomarker tool.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12868-020-00586-0","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T11:02:57Z","timestamp":1599217377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Isolation and characterization of antibody fragments selective for human FTD brain derived TDP-43 variants"],"prefix":"10.1186","volume":"21","author":[{"given":"Lalitha","family":"Venkataraman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent T.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7301-230X","authenticated-orcid":false,"given":"Michael R.","family":"Sierks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"586_CR1","doi-asserted-by":"crossref","unstructured":"Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology. 2002;58(11):1615 LP\u20131621. http:\/\/n.neurology.org\/content\/58\/11\/1615.abstract.","DOI":"10.1212\/WNL.58.11.1615"},{"issue":"3","key":"586_CR2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ana.20203","volume":"56","author":"JR Hodges","year":"2004","unstructured":"Hodges JR, Davies RR, Xuereb JH, Casey B, Broe M, Bak TH, et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol. 2004;56(3):399\u2013406.","journal-title":"Ann Neurol"},{"issue":"2","key":"586_CR3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00401-011-0839-6","volume":"122","author":"KA Josephs","year":"2011","unstructured":"Josephs KA, Hodges JR, Snowden JS, Mackenzie IR, Neumann M, Mann DM, et al. Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol. 2011;122(2):137\u201353.","journal-title":"Acta Neuropathol"},{"key":"586_CR4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000197893","volume":"24","author":"A Kertesz","year":"2009","unstructured":"Kertesz A. Clinical features and diagnosis of frontotemporal dementia. Front Neurol Neurosci. 2009;24:140\u20138.","journal-title":"Front Neurol Neurosci."},{"issue":"4","key":"586_CR5","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2353\/ajpath.2006.060438","volume":"169","author":"DM Sampathu","year":"2006","unstructured":"Sampathu DM, Neumann M, Kwong LK, Chou TT, Micsenyi M, Truax A, et al. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am J Pathol. 2006;169(4):1343\u201352.","journal-title":"Am J Pathol"},{"key":"586_CR6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40478-016-0301-z","volume":"4","author":"R Behrouzi","year":"2016","unstructured":"Behrouzi R, Liu X, Wu D, Robinson AC, Tanaguchi-Watanabe S, Rollinson S, et al. Pathological tau deposition in motor neurone disease and frontotemporal lobar degeneration associated with TDP-43 proteinopathy. Acta Neuropathol Commun. 2016;4:33.","journal-title":"Acta Neuropathol Commun."},{"issue":"9","key":"586_CR7","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1002\/hbm.22515","volume":"35","author":"CT McMillan","year":"2014","unstructured":"McMillan CT, Avants BB, Cook P, Ungar L, Trojanowski JQ, Grossman M. The power of neuroimaging biomarkers for screening frontotemporal dementia. Hum Brain Mapp. 2014;35(9):4827\u201340.","journal-title":"Hum Brain Mapp"},{"issue":"7","key":"586_CR8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nrneurol.2017.75","volume":"13","author":"LH Meeter","year":"2017","unstructured":"Meeter LH, Kaat LD, Rohrer JD, van Swieten JC. Imaging and fluid biomarkers in frontotemporal dementia. Nat Rev Neurol. 2017;13(7):406\u201319.","journal-title":"Nat Rev Neurol."},{"issue":"3","key":"586_CR9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2967\/jnumed.107.045385","volume":"49","author":"L Mosconi","year":"2008","unstructured":"Mosconi L, Tsui WH, Herholz K, Pupi A, Drzezga A, Lucignani G, et al. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer\u2019s disease, and other dementias. J Nucl Med. 2008;49(3):390\u20138.","journal-title":"J Nucl Med"},{"issue":"1\u20132","key":"586_CR10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000381828","volume":"40","author":"N Rostgaard","year":"2015","unstructured":"Rostgaard N, Waldemar G, Nielsen JE, Simonsen AH. Cerebrospinal fluid biomarkers in familial forms of Alzheimer\u2019s Disease and Frontotemporal Dementia. Dement Geriatr Cogn Disord. 2015;40(1\u20132):54\u201362.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"586_CR11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ana.20700","volume":"59","author":"JA Knibb","year":"2006","unstructured":"Knibb JA, Xuereb JH, Patterson K, Hodges JR. Clinical and pathological characterization of progressive aphasia. Ann Neurol. 2006;59(1):156\u201365.","journal-title":"Ann Neurol"},{"issue":"1","key":"586_CR12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1212\/01.wnl.0000287073.12737.35","volume":"70","author":"KA Josephs","year":"2008","unstructured":"Josephs KA, Whitwell JL, Duffy JR, Vanvoorst WA, Strand EA, Hu WT, et al. Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Neurology. 2008;70(1):25\u201334.","journal-title":"Neurology."},{"issue":"Pt 4","key":"586_CR13","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/brain\/awu024","volume":"137","author":"M-M Mesulam","year":"2014","unstructured":"Mesulam M-M, Weintraub S, Rogalski EJ, Wieneke C, Geula C, Bigio EH. Asymmetry and heterogeneity of Alzheimer\u2019s and frontotemporal pathology in primary progressive aphasia. Brain. 2014;137(Pt 4):1176\u201392.","journal-title":"Brain"},{"issue":"3","key":"586_CR14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ana.10825","volume":"55","author":"ML Gorno-Tempini","year":"2004","unstructured":"Gorno-Tempini ML, Dronkers NF, Rankin KP, Ogar JM, Phengrasamy L, Rosen HJ, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol. 2004;55(3):335\u201346.","journal-title":"Ann Neurol"},{"issue":"6","key":"586_CR15","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00401-014-1269-z","volume":"127","author":"KA Josephs","year":"2014","unstructured":"Josephs KA, Whitwell JL, Weigand SD, Murray ME, Tosakulwong N, Liesinger AM, et al. TDP-43 is a key player in the clinical features associated with Alzheimer\u2019s disease. Acta Neuropathol. 2014;127(6):811\u201324.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"586_CR16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00401-016-1537-1","volume":"131","author":"KA Josephs","year":"2016","unstructured":"Josephs KA, Murray ME, Whitwell JL, Tosakulwong N, Weigand SD, Petrucelli L, et al. Updated TDP-43 in Alzheimer\u2019s disease staging scheme. Acta Neuropathol. 2016;131(4):571\u201385.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"586_CR17","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1440-1789.2009.01017.x","volume":"29","author":"A Kadokura","year":"2009","unstructured":"Kadokura A, Yamazaki T, Lemere CA, Takatama M, Okamoto K. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology. Neuropathology. 2009;29(5):566\u201373.","journal-title":"Neuropathology."},{"issue":"9","key":"586_CR18","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/NEN.0b013e31822c62cf","volume":"70","author":"C Tremblay","year":"2011","unstructured":"Tremblay C, St-Amour I, Schneider J, Bennett DA, Calon F. Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol. 2011;70(9):788\u201398.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6686","key":"586_CR19","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/31508","volume":"393","author":"M Hutton","year":"1998","unstructured":"Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, et al. Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393(6686):702\u20135.","journal-title":"Nature"},{"issue":"2","key":"586_CR20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245\u201356.","journal-title":"Neuron"},{"issue":"7105","key":"586_CR21","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05016","volume":"442","author":"M Baker","year":"2006","unstructured":"Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442(7105):916\u20139.","journal-title":"Nature"},{"issue":"5","key":"586_CR22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11910-009-0052-3","volume":"9","author":"WT Hu","year":"2009","unstructured":"Hu WT, Grossman M. TDP-43 and frontotemporal dementia. Curr Neurol Neurosci Rep. 2009;9(5):353\u20138.","journal-title":"Curr Neurol Neurosci Rep."},{"issue":"10","key":"586_CR23","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.biocel.2010.06.016","volume":"42","author":"ST Warraich","year":"2010","unstructured":"Warraich ST, Yang S, Nicholson GA, Blair IP. TDP-43: a DNA and RNA binding protein with roles in neurodegenerative diseases. Int J Biochem Cell Biol. 2010;42(10):1606\u20139.","journal-title":"Int J Biochem Cell Biol"},{"issue":"5796","key":"586_CR24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130\u20133.","journal-title":"Science"},{"key":"586_CR25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","volume":"122","author":"IRA Mackenzie","year":"2011","unstructured":"Mackenzie IRA, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathologica. 2011;122:111\u20133.","journal-title":"Acta Neuropathologica."},{"issue":"11","key":"586_CR26","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1001\/archneur.65.11.1481","volume":"65","author":"P Steinacker","year":"2008","unstructured":"Steinacker P, Hendrich C, Sperfeld AD, Jesse S, von Arnim CAF, Lehnert S, et al. TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch Neurol. 2008;65(11):1481\u20137.","journal-title":"Arch Neurol"},{"key":"586_CR27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/B978-0-444-63945-5.00018-0","volume":"153","author":"JI Ayers","year":"2018","unstructured":"Ayers JI, Cashman NR. Prion-like mechanisms in amyotrophic lateral sclerosis. Handb Clin Neurol. 2018;153:337\u201354.","journal-title":"Handb Clin Neurol."},{"issue":"19","key":"586_CR28","doi-asserted-by":"crossref","first-page":"12845","DOI":"10.1074\/jbc.M808759200","volume":"284","author":"B Frost","year":"2009","unstructured":"Frost B, Jacks RL, Diamond MI. Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem. 2009;284(19):12845\u201352.","journal-title":"J Biol Chem"},{"issue":"Suppl 1(Suppl S","key":"586_CR29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/jnc.13668","volume":"138","author":"E-M Hock","year":"2016","unstructured":"Hock E-M, Polymenidou M. Prion-like propagation as a pathogenic principle in frontotemporal dementia. J Neurochem. 2016;138(Suppl 1(Suppl Suppl 1)):163\u201383.","journal-title":"J Neurochem."},{"issue":"21","key":"586_CR30","doi-asserted-by":"crossref","first-page":"18664","DOI":"10.1074\/jbc.M111.231209","volume":"286","author":"Y Furukawa","year":"2011","unstructured":"Furukawa Y, Kaneko K, Watanabe S, Yamanaka K, Nukina N. A seeding reaction recapitulates intracellular formation of Sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions. J Biol Chem. 2011;286(21):18664\u201372.","journal-title":"J Biol Chem"},{"issue":"1","key":"586_CR31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.celrep.2013.06.007","volume":"4","author":"T Nonaka","year":"2013","unstructured":"Nonaka T, Masuda-Suzukake M, Arai T, Hasegawa Y, Akatsu H, Obi T, et al. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep. 2013;4(1):124\u201334. https:\/\/doi.org\/10.1016\/j.celrep.2013.06.007.","journal-title":"Cell Rep."},{"issue":"17","key":"586_CR32","doi-asserted-by":"crossref","first-page":"8896","DOI":"10.1074\/jbc.M115.713552","volume":"291","author":"S Shimonaka","year":"2016","unstructured":"Shimonaka S, Nonaka T, Suzuki G, Hisanaga S-I, Hasegawa M. Templated aggregation of TAR DNA-binding protein of 43\u00a0kDa (TDP-43) by seeding with TDP-43 peptide fibrils. J Biol Chem. 2016;291(17):8896\u2013907.","journal-title":"J Biol Chem"},{"issue":"Pt 11","key":"586_CR33","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1093\/brain\/aws230","volume":"135","author":"H Tsuji","year":"2012","unstructured":"Tsuji H, Arai T, Kametani F, Nonaka T, Yamashita M, Suzukake M, et al. Molecular analysis and biochemical classification of TDP-43 proteinopathy. Brain. 2012;135(Pt 11):3380\u201391.","journal-title":"Brain"},{"issue":"1","key":"586_CR34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ana.21425","volume":"64","author":"M Hasegawa","year":"2008","unstructured":"Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol. 2008;64(1):60\u201370.","journal-title":"Ann Neurol"},{"issue":"30","key":"586_CR35","doi-asserted-by":"crossref","first-page":"20329","DOI":"10.1074\/jbc.M109.010264","volume":"284","author":"BS Johnson","year":"2009","unstructured":"Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, Gitler AD. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J Biol Chem. 2009;284(30):20329\u201339.","journal-title":"J Biol Chem"},{"key":"586_CR36","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1038\/ncomms5824","volume":"5","author":"Y-S Fang","year":"2014","unstructured":"Fang Y-S, Tsai K-J, Chang Y-J, Kao P, Woods R, Kuo P-H, et al. Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients. Nat Commun. 2014;5:4824.","journal-title":"Nat Commun."},{"issue":"13","key":"586_CR37","doi-asserted-by":"crossref","first-page":"8516","DOI":"10.1074\/jbc.M809462200","volume":"284","author":"LM Igaz","year":"2009","unstructured":"Igaz LM, Kwong LK, Chen-Plotkin A, Winton MJ, Unger TL, Xu Y, et al. Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 Proteinopathies. J Biol Chem. 2009;284(13):8516\u201324.","journal-title":"J Biol Chem"},{"key":"586_CR38","first-page":"254680","volume":"2014","author":"Y Yu","year":"2014","unstructured":"Yu Y, Hayashi S, Cai X, Fang C, Shi W, Tsutsui H, et al. Pu-erh tea extract induces the degradation of FET family proteins involved in the pathogenesis of amyotrophic lateral sclerosis. Biomed Res Int. 2014;2014:254680.","journal-title":"Biomed Res Int"},{"issue":"6","key":"586_CR39","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/jnnp-2013-305972","volume":"85","author":"M Su\u00e1rez-Calvet","year":"2014","unstructured":"Su\u00e1rez-Calvet M, Dols-Icardo O, Llad\u00f3 A, S\u00e1nchez-Valle R, Hern\u00e1ndez I, Amer G, et al. Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation. J Neurol Neurosurg Psychiatry. 2014;85(6):684\u201391.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"586_CR40","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3233\/JAD-160386","volume":"55","author":"HB Kuiperij","year":"2017","unstructured":"Kuiperij HB, Versleijen AAM, Beenes M, Verwey NA, Benussi L, Paterlini A, et al. Tau Rather than TDP-43 proteins are potential cerebrospinal fluid biomarkers for frontotemporal lobar degeneration subtypes: a pilot study. J Alzheimers Dis. 2017;55(2):585\u201395.","journal-title":"J Alzheimers Dis."},{"issue":"5","key":"586_CR41","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00401-009-0594-0","volume":"118","author":"PG Foulds","year":"2009","unstructured":"Foulds PG, Davidson Y, Mishra M, Hobson DJ, Humphreys KM, Taylor M, et al. Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration. Acta Neuropathol. 2009;118(5):647\u201358.","journal-title":"Acta Neuropathol"},{"key":"586_CR42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fnagi.2013.00006","volume":"5","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Trojanowski JQ, Grossman M. Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer\u2019s disease. Front Aging Neurosci. 2013;5:6.","journal-title":"Front Aging Neurosci."},{"issue":"96","key":"586_CR43","first-page":"e52584","volume":"12","author":"SM Williams","year":"2015","unstructured":"Williams SM, Venkataraman L, Tian H, Khan G, Harris BT, Sierks MR. Novel atomic force microscopy based biopanning for isolation of morphology specific reagents against TDP-43 variants in amyotrophic lateral sclerosis. J Vis Exp. 2015;12(96):e52584.","journal-title":"J Vis Exp."},{"issue":"2","key":"586_CR44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00401-012-1048-7","volume":"125","author":"KF Bieniek","year":"2013","unstructured":"Bieniek KF, Murray ME, Rutherford NJ, Castanedes-Casey M, DeJesus-Hernandez M, Liesinger AM, et al. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion. Acta Neuropathol. 2013;125(2):289\u2013302.","journal-title":"Acta Neuropathol"},{"issue":"25","key":"586_CR45","doi-asserted-by":"crossref","first-page":"7241","DOI":"10.1093\/hmg\/ddv424","volume":"24","author":"AK Walker","year":"2015","unstructured":"Walker AK, Tripathy K, Restrepo CR, Ge G, Xu Y, Kwong LK, et al. An insoluble frontotemporal lobar degeneration-associated TDP-43 C-terminal fragment causes neurodegeneration and hippocampus pathology in transgenic mice. Hum Mol Genet. 2015;24(25):7241\u201354.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"586_CR46","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.21344","volume":"63","author":"MA Gitcho","year":"2008","unstructured":"Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D, et al. TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol. 2008;63(4):535\u20138.","journal-title":"Ann Neurol"},{"key":"586_CR47","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.brainres.2007.09.048","volume":"1184","author":"S Higashi","year":"2007","unstructured":"Higashi S, Iseki E, Yamamoto R, Minegishi M, Hino H, Fujisawa K, et al. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer\u2019s disease and dementia with Lewy bodies. Brain Res. 2007;1184:284\u201394.","journal-title":"Brain Res"},{"issue":"12","key":"586_CR48","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/NEN.0b013e31818e8951","volume":"67","author":"C Schwab","year":"2008","unstructured":"Schwab C, Arai T, Hasegawa M, Yu S, McGeer PL. Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease. J Neuropathol Exp Neurol. 2008;67(12):1159\u201365.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"586_CR49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10561-008-9067-2","volume":"9","author":"TG Beach","year":"2008","unstructured":"Beach TG, Sue LI, Walker DG, Roher AE, Lue L, Vedders L, et al. The Sun Health research institute brain donation program: description and experience, 1987-2007. Cell Tissue Bank. 2008;9(3):229\u201345.","journal-title":"Cell Tissue Bank."},{"issue":"4","key":"586_CR50","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/neup.12189","volume":"35","author":"TG Beach","year":"2015","unstructured":"Beach TG, Adler CH, Sue LI, Serrano G, Shill HA, Walker DG, et al. Arizona study of aging and neurodegenerative disorders and brain and body donation program. Neuropathology. 2015;35(4):354\u201389.","journal-title":"Neuropathology."},{"issue":"2","key":"586_CR51","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/btpr.1698","volume":"29","author":"S Kasturirangan","year":"2013","unstructured":"Kasturirangan S, Reasoner T, Schulz P, Boddapati S, Emadi S, Valla J, et al. Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samples. Biotechnol Prog. 2013;29(2):463\u201371.","journal-title":"Biotechnol Prog"},{"issue":"4","key":"586_CR52","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/jre.12227","volume":"50","author":"H Murata","year":"2015","unstructured":"Murata H, Hattori T, Maeda H, Takashiba S, Takigawa M, Kido J, et al. Identification of transactivation-responsive DNA-binding protein 43 (TARDBP43; TDP-43) as a novel factor for TNF-\u03b1 expression upon lipopolysaccharide stimulation in human monocytes. J Periodontal Res. 2015;50(4):452\u201360.","journal-title":"J Periodontal Res"},{"key":"586_CR53","unstructured":"Human Single Fold scFv Libraries I\u2009+\u2009J (Tomlinson I\u2009+\u2009J) http:\/\/docplayer.net\/30268507-Human-single-fold-scfv-libraries-i-j-tomlinson-i-j.html."},{"issue":"22","key":"586_CR54","first-page":"6157","volume":"95","author":"A Dierich","year":"1998","unstructured":"Dierich A, Sairam MR, Mo- L, Fimia GM, Gansmuller A, Lemeur M, et al. Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens. Cell Biol. 1998;95(22):6157\u201362.","journal-title":"Cell Biol."},{"key":"586_CR55","doi-asserted-by":"crossref","unstructured":"Emadi S, Barkhordarian H, Wang MS, Schulz P, Sierks MR. Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicity. J Mol Biol. 2007; 368(4):1132\u201344. http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=2235820&tool=pmcentrez&rendertype=abstract. Accessed 10 Oct 2012","DOI":"10.1016\/j.jmb.2007.02.089"},{"issue":"1","key":"586_CR56","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/btpr.1987","volume":"31","author":"S Williams","year":"2015","unstructured":"Williams S, Schulz P, Sierks MR. A sensitive phage-based capture ELISA for sub-femtomolar detection of protein variants directly from biological samples. Biotechnol Prog. 2015;31(1):289\u201398.","journal-title":"Biotechnol Prog"},{"key":"586_CR57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neurobiolaging.2020.04.014","volume":"94","author":"L Venkataraman","year":"2020","unstructured":"Venkataraman L, He P, Schulz P, Sierks MR. Isolation and characterization of antibody fragment selective for human Alzheimer\u2019s disease brain-derived tau variants. Neurobiol Aging. 2020;94:7\u201314.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"586_CR58","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3233\/JAD-2011-111196","volume":"28","author":"S Boddapati","year":"2012","unstructured":"Boddapati S, Levites Y, Suryadi V, Kasturirangan S, Sierks MR. Bispecific tandem single chain antibody simultaneously inhibits \u03b2-secretase and promotes \u03b1-secretase processing of A\u03b2PP. J Alzheimers Dis. 2012;28(4):961\u20139.","journal-title":"J Alzheimers Dis."},{"issue":"1","key":"586_CR59","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12868-017-0334-7","volume":"18","author":"SM Williams","year":"2017","unstructured":"Williams SM, Khan G, Harris BT, Ravits J, Sierks MR. TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis. BMC Neurosci. 2017;18(1):20.","journal-title":"BMC Neurosci."},{"issue":"3","key":"586_CR60","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.3390\/biom5031634","volume":"5","author":"W Xin","year":"2015","unstructured":"Xin W, Emadi S, Williams S, Liu Q, Schulz P, He P, et al. Toxic Oligomeric Alpha-synuclein variants present in human parkinson\u2019s disease brains are differentially generated in mammalian cell models. Biomolecules. 2015;5(3):1634\u201351.","journal-title":"Biomolecules."}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-020-00586-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12868-020-00586-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-020-00586-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T23:50:00Z","timestamp":1630713000000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/s12868-020-00586-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["586"],"URL":"https:\/\/doi.org\/10.1186\/s12868-020-00586-0","relation":{},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,4]]},"assertion":[{"value":"27 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Post-mortem human brain tissue samples were provided with no identifiable patient information from the Georgetown Brain Bank (Georgetown University Medical Center). Anonymized post-mortem human brain tissue and sera samples were provided by Dr. Thomas Beach, Brain and Body Donation Program at Banner Sun Health Research Institute All tissue\/biofluid banks are operating under institutional IRB guidelines. All experiments were approved by the Office of Research Integrity and Assurance at Arizona State University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"M Sierks is cofounder and CSO of Studio Biotherapeutics. All other authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}